Nutrition In The Prevention And Treatment Of Ab...
Stress fractures are common bone injuries suffered by athletes that have a different etiology than contact fractures, which also have a frequent occurrence, particularly in contact sports. Stress fractures are overuse injuries of the bone that are caused by the rhythmic and repeated application of mechanical loading in a subthreshold manner (McBryde, 1985). Given this, athletes involved in high-volume, high-intensity training, where the individual is body weight loaded, are particularly susceptible to developing a stress fracture (Fredericson et al., 2007), and training time lost can be significant (Ranson et al., 2010). The pathophysiology of stress fracture injuries is complex and not completely understood (Bennell et al., 1999), but some studies have suggested that nutritional inadequacies could be considered a risk factor (Moran et al., 2012). That said, there is little direct information relating to the role of diet and nutrition in either the prevention or recovery from bone injuries, such as stress fractures. As such, the completion of this article requires some extrapolation from the information relating to the effects of diet and nutrition on bone health in general.
Nutrition in the Prevention and Treatment of Ab...
There is a myriad of other nutrients that are purported to improve tendon/ligament function, including turmeric/curcumin, taurine, arginine, bromelain, or boswellic acid. These and other nutraceuticals have recently been reviewed by Fusini et al. (2016). Interestingly, many of these nutrients are thought to decrease inflammation, and the role of inflammation in tendinopathy in elite athletes remains controversial (Peeling et al., 2018). Therefore, future work is needed to validate these purported nutraceuticals in the prevention or treatment of tendon or ligament injuries.
This Consensus Report is intended to provide clinical professionals with evidence-based guidance about individualizing nutrition therapy for adults with diabetes or prediabetes. Strong evidence supports the efficacy and cost-effectiveness of nutrition therapy as a component of quality diabetes care, including its integration into the medical management of diabetes; therefore, it is important that all members of the health care team know and champion the benefits of nutrition therapy and key nutrition messages. Nutrition counseling that works toward improving or maintaining glycemic targets, achieving weight management goals, and improving cardiovascular risk factors (e.g., blood pressure, lipids, etc.) within individualized treatment goals is recommended for all adults with diabetes and prediabetes.
For more information on fat intake and CVD risk, see the section role of nutrition therapy in the prevention and management of diabetes complications (cvd, diabetic kidney disease, and gastroparesis).
Consultation by an RDN knowledgeable in the management of gastroparesis is helpful in setting and maintaining treatment goals (324). Treatment goals include managing and reducing symptoms; correcting fluid, electrolyte, and nutritional deficiencies and glycemic imbalances; and addressing the precipitating cause(s) with appropriate drug therapy (227). Correcting hyperglycemia is one strategy for the management of gastroparesis, as acute hyperglycemia delays gastric emptying (325,326). Modification of food and beverage intake is the primary management strategy, especially among individuals with mild symptoms.
Current nutrition therapy recommendations for the prevention and treatment of diabetes are based on a systematic review of evidence and answer important nutrition care questions. First, is diabetes nutrition therapy effective? Clinical trials as well as systematic and Cochrane reviews report a 1%-2% lowering of hemoglobin A1c values as well as other beneficial outcomes from nutrition therapy interventions, depending on the type and duration of diabetes and level of glycemic control. Clinical trials also provide evidence for the effectiveness of nutrition therapy in the prevention of diabetes. Second, are weight loss interventions important and when are they beneficial? Modest weight loss is important for the prevention of type 2 diabetes and early in the disease process. However, as diabetes progresses, weight loss may or may not result in beneficial glycemic and cardiovascular outcomes. Third, are there ideal percentages of macronutrients and eating patterns that apply to all persons with diabetes? There is no ideal percentage of macronutrients and a variety of eating patterns has been shown to be effective for persons with diabetes. Treatment goals, personal preferences (eg, tradition, culture, religion, health beliefs, economics), and the individual's ability and willingness to make lifestyle changes must all be considered by clinicians and/or educators when counseling and educating individuals with diabetes. A healthy eating pattern emphasizing nutrient-dense foods in appropriate portion sizes, regular physical activity, and support are priorities for all individuals with diabetes. Reduced energy intake for persons with prediabetes or type 2 diabetes as well as matching insulin to planned carbohydrate intake are intervention to be considered. Fourth, is the question of how to implement nutrition therapy interventions in clinical practice. This requires nutrition care strategies.
2. A team-based care approach is an effective strategy for the prevention of cardiovascular disease. Clinicians should evaluate the social determinants of health that affect individuals to inform treatment decisions.
The purpose of this systematic review is to examine the current evidence for providing nutrition screening and interventions before or during cancer therapy on cancer care outcomes. Results from the review will describe the current body of scientific evidence available for shaping clinical guidelines on prevention and treatment of malnutrition in cancer care, and provide a summary and synthesis of the available evidence for clinical and policy stakeholders to use in the development of such guidelines.
KQ1: Evaluate the effect of nutritional interventions prior to cancer treatment in preventing the negative outcomes associated with cancer treatment such as effects on dose tolerance, hospital utilizations, adverse events and survival in adults diagnosed with cancer who have or are at risk for cancer-associated malnutrition.
KQ2: Evaluate the effect of nutritional interventions during cancer treatment in preventing the negative outcomes associated with cancer treatment such as effects on dose tolerance, hospital utilizations, adverse events and survival in adults diagnosed with cancer who have or are at risk for cancer-associated malnutrition.
KQ3: Evaluate the effect of nutritional interventions on symptoms associated with cancer treatment, such as fatigue, nausea and vomiting, appetite, physical and functional status (e.g., frailty), and quality of life among adults with cancer who will be or are undergoing cancer treatment.
Includes nutritional interventions under the supervision of a nutrition professional (e.g., dietician, nutritionist, or other licensed clinicians). Pre-treatment nutritional interventions (KQ1,3,4) include interventions delivered between the initial cancer diagnosis and initiation of any cancer therapy (e.g., systemic therapy, radiation, surgery). Nutritional interventional during cancer therapy (KQ 2, 3, 4) include interventions delivered simultaneously (at least in part) with cancer therapy (e.g., systemic therapy, radiation, surgery), regardless of treatment intent (e.g., curative vs. palliative).
Pre-treatment nutritional interventions includes any intervention delivered from the date of diagnosis through the initiation of cancer-directed therapy. Nutritional interventional during cancer therapy (KQ 2, 3, 4) include interventions delivered simultaneously (at least in part) with cancer therapy (e.g., systemic therapy, radiation, surgery), regardless of treatment intent (e.g., curative vs. palliative).
A lecture and reading course for graduate students to review current research and the scientific basis of nutrition intervention in the prevention and treatment of chronic human disease. Translation of research findings to nutrition recommendations in topical areas including global health and food supply, obesity, cardiovascular disease, polycystic ovary syndrome and behavior-cognitive disorders. Not to be taken if credit received for NUTR 452. Prerequisite: consent of instructor. *6 PHYSL recommended.
A lecture and reading course to review current research and the scientific basis of nutrition intervention in the prevention and treatment of chronic human disease. Translation of research findings to nutrition recommendations in topical areas including global health and food supply, obesity, cardiovascular disease, polycystic ovary syndrome and behavior-cognitive disorders. Prerequisites: (NUTR 302, NUTR 304, or NU FS 305) and NU FS 356. *6 PHYSL recommended.
SAMHSA requires that grantees spend no less than 20% of their SABG allotment on substance abuse primary prevention strategies. These strategies are directed at individuals not identified to be in need of treatment.
The Substance Abuse and Mental Health (SAMH) Program is responsible for the oversight of a statewide system of care for the prevention, treatment, and recovery of children and adults with serious mental illnesses or substance abuse disorders.
Prevention is the best treatment! However, if refeeding syndrome is suspected, a patient should be hospitalized and aggressive correction of electrolytes needs to occur, either orally or through the intravenous route, depending on the serum values. Patients also require very close cardiorespiratory monitoring given the increased risk of heart failure and arrhythmias, close monitoring of lab values, vitamin supplementation and close monitoring of nutritional intake and daily weights. Treatment and stabilization need to be addressed immediately. 041b061a72